Table of Contents

company-logo

Rafarma Pharmaceuticals, Inc., a multi-product pharmaceutical company, produces and sells drugs, generic antibiotics, and specialty pharmaceuticals in Russia. It offers cephalosporin-based products, antibiotics of non-ß structure, and anti-cancer drugs in the form of injections, ampulla packaged products, child suspensions, tablets, and capsules. The company also provides drugs for accidental wounds, inflammatory eye diseases, and immunological disorders. The company has a collaboration agreement with PlantEXT Ltd. to research and manufacture the first medical cannabis suppositories for patients suffering from inflammatory bowel disease. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012. The company is based in Sandy, Utah with a manufacturing and distribution facility in Russia. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R. & D. Biocogency Laboratories Inc. Ltd.

Rafarma Pharmaceuticals Dividend Announcement

• Rafarma Pharmaceuticals does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Rafarma Pharmaceuticals dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Rafarma Pharmaceuticals Dividend History

Rafarma Pharmaceuticals Dividend Yield

Rafarma Pharmaceuticals current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Rafarma Pharmaceuticals stock? Use our calculator to estimate your expected dividend yield:

Rafarma Pharmaceuticals Financial Ratios

P/E ratio5.48
PEG ratio0.05
P/B ratio0.49
ROE2.70%
Payout ratio0.00%
Current ratio1.14
Quick ratio0.89
Cash Ratio0.01

Rafarma Pharmaceuticals Dividend FAQ

Does Rafarma Pharmaceuticals stock pay dividends?
Rafarma Pharmaceuticals does not currently pay dividends to its shareholders.
Has Rafarma Pharmaceuticals ever paid a dividend?
No, Rafarma Pharmaceuticals has no a history of paying dividends to its shareholders. Rafarma Pharmaceuticals is not known for its dividend payments.
Why doesn't Rafarma Pharmaceuticals pay dividends?
There are several potential reasons why Rafarma Pharmaceuticals would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Rafarma Pharmaceuticals ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Rafarma Pharmaceuticals has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Rafarma Pharmaceuticals a dividend aristocrat?
Rafarma Pharmaceuticals is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Rafarma Pharmaceuticals a dividend king?
Rafarma Pharmaceuticals is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Rafarma Pharmaceuticals a dividend stock?
No, Rafarma Pharmaceuticals is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Rafarma Pharmaceuticals stocks?
To buy Rafarma Pharmaceuticals you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Rafarma Pharmaceuticals stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.